Artificial Pancreas Market provide a detailed analysis, mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc.
Pune, India -- (SBWIRE) -- 12/22/2017 -- Market Highlights
The present market is dominated by the threshold suspended device segment and Medtronic's device series MiniMed leads the market for threshold suspended device segment. The artificial pancreas market is chiefly driven by rise in diabetes which is again driven by rise in risk factors such as sedentary lifestyles, unhealthy foods such as fast foods with poor fibre content, high sugar content, lack of exercise etc. Other drivers of anal fissures include the rising screening for diabetes.
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/3854 .
The threshold suspend device system act by temporarily suspending infusion of insulin, when the body glucose level falls to a set low threshold. These systems require frequent patient inputs to avoid a hypoglycaemic event. However, the control-to-range (CTR) system, and control-to-target (CTT) system are expected to gain momentum due to the greater automation, low manual input requirement and their ability to more precisely mimic the working of the natural pancreas system.Remote monitoring and connected artificial pancreas systems are expected to represent the future of the technology.
Several closed loop systems including Inreda's artificial pancreas, Bionic pancreas etc. are in advanced stages of testing for remote monitoring. Another advancement has been the development of the bi-hormonal system which delivers insulin along with another hormone such as glucagon to increase blood glucose levels and more closely mimics the glucose-regulating function of a healthy pancreas than the insulin-only system.
Beta Bionics has developed the iLet Bionic Pancreas system that delivers both insulin and glucagon and is targeted to type 1 diabetes patients; and was developed by Dr. Ed Damiano at the Boston University. Thus, by 2019 products of these key players are anticipated to commercially exist in the market which would increase the market competition, new pricing strategies, assist merger and acquisitions, and geographical expansion strategies.
Global Artificial pancreas Market Players:
Key players profiled in the report are Medtronic, Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, Admetsys (pipeline product analysis), Animas Corporation, Defymed, dexcom, Insulet, Johnson & Johnson, medtech, medtronic, Semma Therapeutics, Tandem Diabetes Care, TypeZero Technologies, and others.
Test the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on "Global Artificial pancreas Market" Research Report – Forecast to 2023.
Order Single User License Copy of 110 Premium Pages is Available @ https://www.marketresearchfuture.com/reports/artificial-pancreas-market-3854 .
The global Artificial Pancreas market is segmented on the basis of type and end users. Based on type, the market has been segmented as threshold suspend device system, non-threshold suspend device system, control-to-range (CTR) system, and control-to-target (CTT) system. Based on the treatment type, the market has been segmented as insulin only, bi-hormonal, and hybrid. Based on the end users, the market has been segmented as hospitals and clinics, research, and others.
Market Factor Analysis
Global Artificial Pancreas Market, By Control Type
Global Artificial Pancreas Market, By Treatment Type
Global Artificial Pancreas Market, By End Users
Global Artificial Pancreas Market, By Region
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/3854 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.